1

OpenAI Acquires Orchestra Bio to Enter Life Sciences

marketbrief.now

OpenAI has acquired biotechnology firm Orchestra Bio to expand its technical capabilities into biological study and apply its models to the life sciences sector.

Sign in to suggest

Key sources

  1. SOURCEopenai.com
  2. SOURCEhuggingnewshuggingnews.com
  3. SOURCEtechmeme.com
  4. SOURCEtechcrunch.com
  5. SOURCE@madisonmills22“latest major example of AI labs moving into life sciences”x.com
  6. SOURCE@openai“help biopharma teams coordinate the complex process of drug development”x.com
  7. SUPPORT@axios“Exclusive: OpenAI has acquired Orchestra Bio”x.com
  8. SUPPORT@cpmou2022“openai is going big on life sciences”x.com
Markdown